Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 May;34(3):260-2.
doi: 10.3785/j.issn.1008-9292.2005.03.014.

[Determination of interleukine-16 levels in peritoneal fluid and serum of women with endometriosis]

[Article in Chinese]
Affiliations

[Determination of interleukine-16 levels in peritoneal fluid and serum of women with endometriosis]

[Article in Chinese]
Jun Lin et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 May.

Abstract

Objective: To investigate the role of interleukine-16 (IL-16) in the pathogenesis of endometriosis.

Methods: Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of IL-16 in peritoneal fluid and serum specimens of 22 women with different stage endometriosis and 22 controls.

Results: The median levels of IL-16 in peritoneal fluid and serum were 290.5 pg/ml and 539.4 pg/ml in women with endometriosis, and 296.6 pg/ml and 778.1 pg/ml in controls, respectively; there was no significant difference between two groups (P>0.05). However, the IL-16 levels in peritoneal fluid and serum of patients with minimal/mild stage endometriosis and controls were all significantly higher than those of patients with moderate/severe endometriosis (P<0.01, <0.05). In addition, there was no statistical correlation of peritoneal IL-16 levels with those in serum (P>0.05).

Conclusion: Reduced levels of IL-16 in peritoneal fluid and serum of women with advanced stage endometriosis may imply a role of IL-16 in the development and progression of endometriosis.

PubMed Disclaimer

Publication types